RNA Sequencing Market - Forecasts from 2025 to 2030
Description
The RNA sequencing market is projected to grow at a CAGR of 10.49% between 2025 and 2030
RNA sequencing is a known technique that is used to examine the sequences and quantity of RNA in a sample using next-generation sequencing (NGS). The major applications of RNA sequencing are investigating and discovering the transcriptome and the total cellular content of RNAs, including mRNA, rRNA, and tRNA. This allows scientists to understand the overall biology of a cell and assess changes that may indicate disease. Some of the most popular techniques that use RNA sequencing are transcriptional profiling, SNP identification, RNA editing, and differential gene expression analysis. RNA sequencing is considered more valuable as it is not limited to genomic sequences, has a low background signal, and is highly quantifiable.
Market Trends:
Growing Industry Adoption Fuels RNA Sequencing Market: The widespread uptake of RNA sequencing across various sectors is expected to propel market growth. Compared to traditional methods, RNA sequencing offers superior sensitivity for detecting genes with low or extremely high expression levels and a broader dynamic range (>8000-fold) for identifying transcripts. It provides deeper insights into a cell’s transcriptome, enhanced by recent advancements in the RNA-Seq process—from sample preparation and library construction to data analysis. Its proven efficacy, particularly in advancing treatments for diseases like cancer, has driven adoption by leading industries, strengthening healthcare systems and boosting market expansion.
Government Support Boosts Market Potential: Increased backing from government and private entities is creating a positive outlook for the RNA sequencing market. Many developing nations have ramped up investments in research and development, focusing on RNA sequencing initiatives to deepen understanding of genetics and disease. Government bodies have actively engaged in sequencing programs aimed at improving treatments for cancer and other conditions. This support has spurred the entry of new players and the launch of numerous RNA sequencing projects, fostering industry growth and opening opportunities for established companies.
North America Sees Rapid Growth: North America is experiencing significant market expansion during the forecast period, driven by the rapid development of structure-based drug design, a growing emphasis on transcriptomics research, and substantial investments in biopharmaceutical R&D. The region’s pharmaceutical sector is seeing robust growth, largely due to heightened spending on research and drug development, which serves as a key driver for market leaders’ revenue gains.
Some of the major players covered in this report Roche Holding AG, Agilent Technologies, Illumina, Inc., Thermo Fisher Scientific, Macrogen, Inc., Beijing Genomics Institute, Qiagen, DNASTAR, GATC Biotech AG, Pacific Biosciences of California, Inc., among others.
Key Benefits of this Report:
Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Report Coverage:
Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
RNA Sequencing Market Segmentation:
By Technology
Ion Semiconductor Sequencing
Single-Molecule Real-Time (SMRT) Sequencing
Nanopore Sequencing
Sequencing By Synthesis (SBS)
By Applications
Small RNA Sequencing
Expression Profiling Analysis
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
RNA Editing
By End-User
Research Centers
Biotechnology Labs
Healthcare Centers
Others
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
Spain
United Kingdom
Others
Middle East and Africa
UAE
Saudi Arabia
Others
Asia Pacific
China
Japan
India
South Korea
Thailand
Indonesia
Taiwan
Others
RNA sequencing is a known technique that is used to examine the sequences and quantity of RNA in a sample using next-generation sequencing (NGS). The major applications of RNA sequencing are investigating and discovering the transcriptome and the total cellular content of RNAs, including mRNA, rRNA, and tRNA. This allows scientists to understand the overall biology of a cell and assess changes that may indicate disease. Some of the most popular techniques that use RNA sequencing are transcriptional profiling, SNP identification, RNA editing, and differential gene expression analysis. RNA sequencing is considered more valuable as it is not limited to genomic sequences, has a low background signal, and is highly quantifiable.
Market Trends:
Growing Industry Adoption Fuels RNA Sequencing Market: The widespread uptake of RNA sequencing across various sectors is expected to propel market growth. Compared to traditional methods, RNA sequencing offers superior sensitivity for detecting genes with low or extremely high expression levels and a broader dynamic range (>8000-fold) for identifying transcripts. It provides deeper insights into a cell’s transcriptome, enhanced by recent advancements in the RNA-Seq process—from sample preparation and library construction to data analysis. Its proven efficacy, particularly in advancing treatments for diseases like cancer, has driven adoption by leading industries, strengthening healthcare systems and boosting market expansion.
Government Support Boosts Market Potential: Increased backing from government and private entities is creating a positive outlook for the RNA sequencing market. Many developing nations have ramped up investments in research and development, focusing on RNA sequencing initiatives to deepen understanding of genetics and disease. Government bodies have actively engaged in sequencing programs aimed at improving treatments for cancer and other conditions. This support has spurred the entry of new players and the launch of numerous RNA sequencing projects, fostering industry growth and opening opportunities for established companies.
North America Sees Rapid Growth: North America is experiencing significant market expansion during the forecast period, driven by the rapid development of structure-based drug design, a growing emphasis on transcriptomics research, and substantial investments in biopharmaceutical R&D. The region’s pharmaceutical sector is seeing robust growth, largely due to heightened spending on research and drug development, which serves as a key driver for market leaders’ revenue gains.
Some of the major players covered in this report Roche Holding AG, Agilent Technologies, Illumina, Inc., Thermo Fisher Scientific, Macrogen, Inc., Beijing Genomics Institute, Qiagen, DNASTAR, GATC Biotech AG, Pacific Biosciences of California, Inc., among others.
Key Benefits of this Report:
Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Report Coverage:
Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
RNA Sequencing Market Segmentation:
By Technology
Ion Semiconductor Sequencing
Single-Molecule Real-Time (SMRT) Sequencing
Nanopore Sequencing
Sequencing By Synthesis (SBS)
By Applications
Small RNA Sequencing
Expression Profiling Analysis
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
RNA Editing
By End-User
Research Centers
Biotechnology Labs
Healthcare Centers
Others
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
Spain
United Kingdom
Others
Middle East and Africa
UAE
Saudi Arabia
Others
Asia Pacific
China
Japan
India
South Korea
Thailand
Indonesia
Taiwan
Others
Table of Contents
145 Pages
- 1. INTRODUCTION
- 1.1. Market Overview
- 1.2. Market Definition
- 1.3. Scope of the Study
- 1.4. Market Segmentation
- 1.5. Currency
- 1.6. Assumptions
- 1.7. Base and Forecast Years Timeline
- 1.8. Key Benefits to the Stakeholder
- 2. RESEARCH METHODOLOGY
- 2.1. Research Design
- 2.2. Research Processes
- 3. EXECUTIVE SUMMARY
- 3.1. Key Findings
- 4. MARKET DYNAMICS
- 4.1. Market Drivers
- 4.2. Market Restraints
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
- 4.4. Industry Value Chain Analysis
- 4.5. Analyst View
- 5. RNA SEQUENCING MARKET BY TECHNOLOGY
- 5.1. Introduction
- 5.2. Ion Semiconductor Sequencing
- 5.3. Single-Molecule Real-Time (SMRT) Sequencing
- 5.4. Nanopore Sequencing
- 5.5. Sequencing By Synthesis (SBS)
- 6. RNA SEQUENCING MARKET BY APPLICATION
- 6.1. Introduction
- 6.2. Small RNA Sequencing
- 6.3. Expression Profiling Analysis
- 6.4. De Novo Transcriptome Assembly
- 6.5. Variant Calling and Transcriptome Epigenetics
- 6.6. RNA Editing
- 7. RNA SEQUENCING MARKET BY END-USER
- 7.1. Introduction
- 7.2. Research Centers
- 7.3. Biotechnology Labs
- 7.4. Healthcare Centers
- 7.5. Others
- 8. RNA SEQUENCING MARKET BY GEOGRAPHY
- 8.1. Introduction
- 8.2. North America
- 8.2.1. By Technology
- 8.2.2. By Application
- 8.2.3. By End-User
- 8.2.4. By Country
- 8.2.4.1. United States
- 8.2.4.2. Canada
- 8.2.4.3. Mexico
- 8.3. South America
- 8.3.1. By Technology
- 8.3.2. By Application
- 8.3.3. By End-User
- 8.3.4. By Country
- 8.3.4.1. Brazil
- 8.3.4.2. Argentina
- 8.3.4.3. Others
- 8.4. Europe
- 8.4.1. By Technology
- 8.4.2. By Application
- 8.4.3. By End-User
- 8.4.4. By Country
- 8.4.4.1. Germany
- 8.4.4.2. France
- 8.4.4.3. Spain
- 8.4.4.4. United Kingdom
- 8.4.4.5. Others
- 8.5. Middle East and Africa
- 8.5.1. By Technology
- 8.5.2. By Application
- 8.5.3. By End-User
- 8.5.4. By Country
- 8.5.4.1. UAE
- 8.5.4.2. Saudi Arabia
- 8.5.4.3. Others
- 8.5.5. By Technology
- 8.5.6. By Application
- 8.5.7. By End-User
- 8.5.8. By Country
- 8.5.8.1. China
- 8.5.8.2. Japan
- 8.5.8.3. India
- 8.5.8.4. South Korea
- 8.5.8.5. Thailand
- 8.5.8.6. Indonesia
- 8.5.8.7. Taiwan
- 8.5.8.8. Others
- 9. COMPETITIVE ENVIRONMENT AND ANALYSIS
- 9.1. Major Players and Strategy Analysis
- 9.2. Market Share Analysis
- 9.3. Mergers, Acquisitions, Agreements, and Collaborations
- 9.4. Competitive Dashboard
- 10. COMPANY PROFILES
- 10.1. Roche Holding AG
- 10.2. Agilent Technologies
- 10.3. Illumina, Inc.
- 10.4. Thermo Fisher Scientific
- 10.5. Macrogen, Inc.
- 10.6. Beijing Genomics Institute
- 10.7. Qiagen
- 10.8. DNASTAR
- 10.9. GATC Biotech AG
- 10.10. Pacific Biosciences of California, Inc.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
